Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases

Inclusion Criteria

• •1. Non-small cell lung cancer confirmed by pathological histology.
• •2. More than 3 metastatic lesions.
• •3. No brain metastases or stable lesions.
• •4. Negative for driver genes (including EGFR, ALK, ROS, BRAF, MET, RET).
• •5. Performance status (PS) score of 0-1, with an expected survival period of more than 3 months.
• •6. Age between 18 and 75 years old.
• •7. Assessment by PET-CT (including FDG and FMISO, not mandatory).
• •8. No contraindications to immunotherapy and radiotherapy.
• •9. Signed the informed consent form.